Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4060172rdf:typepubmed:Citationlld:pubmed
pubmed-article:4060172lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0012013lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0040287lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C1149831lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0220927lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0442120lld:lifeskim
pubmed-article:4060172lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:4060172pubmed:issue1-2lld:pubmed
pubmed-article:4060172pubmed:dateCreated1985-12-5lld:pubmed
pubmed-article:4060172pubmed:abstractTextThe tissue distribution of diazinon and the inhibition of cholinesterase (ChE) activities in plasma, erythrocyte and brain were investigated using male rats and mice which received a single intraperitoneal (i.p.) dose of diazinon (20 or 100 mg/kg body wt) in olive oil. The blood diazinon level was estimated to reach a maximum at 1-2 h after the i.p. administration. It was demonstrated that the diazinon residue levels are the highest in the kidney, when comparing the distribution of diazinon among liver, kidney and brain in the animals after dosing. It was indicated that the ChE inhibition by diazinon exposure is greater in the plasma than in the erythrocytes for male mice, while its inhibition is greater in the erythrocytes for male rats. Brain ChE activity was also inhibited markedly in the mice after dosing.lld:pubmed
pubmed-article:4060172pubmed:languageenglld:pubmed
pubmed-article:4060172pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4060172pubmed:citationSubsetIMlld:pubmed
pubmed-article:4060172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4060172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4060172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4060172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4060172pubmed:statusMEDLINElld:pubmed
pubmed-article:4060172pubmed:monthOctlld:pubmed
pubmed-article:4060172pubmed:issn0300-483Xlld:pubmed
pubmed-article:4060172pubmed:authorpubmed-author:HiraiYYlld:pubmed
pubmed-article:4060172pubmed:authorpubmed-author:KogaNNlld:pubmed
pubmed-article:4060172pubmed:authorpubmed-author:HasegawaTTlld:pubmed
pubmed-article:4060172pubmed:authorpubmed-author:TomokuniKKlld:pubmed
pubmed-article:4060172pubmed:issnTypePrintlld:pubmed
pubmed-article:4060172pubmed:volume37lld:pubmed
pubmed-article:4060172pubmed:ownerNLMlld:pubmed
pubmed-article:4060172pubmed:authorsCompleteYlld:pubmed
pubmed-article:4060172pubmed:pagination91-8lld:pubmed
pubmed-article:4060172pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:meshHeadingpubmed-meshheading:4060172-...lld:pubmed
pubmed-article:4060172pubmed:year1985lld:pubmed
pubmed-article:4060172pubmed:articleTitleThe tissue distribution of diazinon and the inhibition of blood cholinesterase activities in rats and mice receiving a single intraperitoneal dose of diazinon.lld:pubmed
pubmed-article:4060172pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4060172pubmed:publicationTypeComparative Studylld:pubmed